Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world antiviral strategies in previously treated children with chronic hepatitis B
ChiCTR2400086084Phase 4Not yet recruiting
- Sponsor
- The Fifth Medical Center of the PLA General Hospital
- Start
- Jun 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of interferon alfa in Chronic Hepatitis B (CHB) (3 arms), sponsored by The Fifth Medical Center of the PLA General Hospital. Primary endpoint: HBsAg negative conversion rate (clinical cure rate). Planned start Jun 2024; status: not yet recruiting.
02
Drugs
interferon alfa
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2400086084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086084.